Ocular Therapeutix, Inc. (FRA:0OT)
Germany
· Delayed Price · Currency is EUR 10.63
+0.54 (5.30%)
At close: Dec 5, 2025
Ocular Therapeutix Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 55.78 | 63.72 | 58.44 | 51.49 | 43.52 | 17.4 | Upgrade
|
| Revenue Growth (YoY) | -9.21% | 9.03% | 13.49% | 18.32% | 150.08% | 311.71% | Upgrade
|
| Cost of Revenue | 193.5 | 133.26 | 66.34 | 58 | 54.49 | 30.78 | Upgrade
|
| Gross Profit | -137.71 | -69.54 | -7.89 | -6.51 | -10.97 | -13.37 | Upgrade
|
| Selling, General & Admin | 126.22 | 103.84 | 74.49 | 72.15 | 67.07 | 49.47 | Upgrade
|
| Operating Expenses | 126.22 | 103.84 | 74.49 | 72.15 | 67.07 | 49.47 | Upgrade
|
| Operating Income | -263.93 | -173.38 | -82.38 | -78.65 | -78.04 | -62.85 | Upgrade
|
| Interest Expense | -12.11 | -13.58 | -11.34 | -7.02 | -6.67 | -6.77 | Upgrade
|
| Interest & Investment Income | 15.68 | 20.28 | 3.98 | 0.8 | 0.03 | 0.17 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.44 | -0.48 | -5.19 | 13.84 | 78.12 | -86.19 | Upgrade
|
| EBT Excluding Unusual Items | -262.8 | -167.16 | -94.93 | -71.04 | -6.55 | -155.64 | Upgrade
|
| Merger & Restructuring Charges | 13.1 | 1.6 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | -27.95 | 14.19 | - | - | - | Upgrade
|
| Pretax Income | -249.67 | -193.51 | -80.74 | -71.04 | -6.55 | -155.64 | Upgrade
|
| Net Income | -249.67 | -193.51 | -80.74 | -71.04 | -6.55 | -155.64 | Upgrade
|
| Net Income to Common | -249.67 | -193.51 | -80.74 | -71.04 | -6.55 | -155.64 | Upgrade
|
| Shares Outstanding (Basic) | 174 | 158 | 80 | 77 | 76 | 61 | Upgrade
|
| Shares Outstanding (Diluted) | 174 | 158 | 86 | 83 | 82 | 61 | Upgrade
|
| Shares Change (YoY) | 26.34% | 84.90% | 3.57% | 0.59% | 35.24% | 34.19% | Upgrade
|
| EPS (Basic) | -1.44 | -1.22 | -1.01 | -0.92 | -0.09 | -2.56 | Upgrade
|
| EPS (Diluted) | -1.44 | -1.22 | -1.02 | -0.97 | -0.98 | -2.56 | Upgrade
|
| Free Cash Flow | -199.44 | -135.97 | -76.32 | -63.32 | -66.74 | -54.4 | Upgrade
|
| Free Cash Flow Per Share | -1.15 | -0.86 | -0.89 | -0.77 | -0.81 | -0.90 | Upgrade
|
| Gross Margin | -246.87% | -109.13% | -13.51% | -12.64% | -25.20% | -76.85% | Upgrade
|
| Operating Margin | -473.14% | -272.08% | -140.96% | -152.74% | -179.31% | -361.13% | Upgrade
|
| Profit Margin | -447.58% | -303.67% | -138.15% | -137.95% | -15.06% | -894.31% | Upgrade
|
| Free Cash Flow Margin | -357.52% | -213.37% | -130.59% | -122.96% | -153.36% | -312.56% | Upgrade
|
| EBITDA | -259.91 | -169.6 | -79.4 | -76.55 | -75.62 | -60.07 | Upgrade
|
| EBITDA Margin | - | -266.14% | -135.86% | -148.65% | -173.74% | - | Upgrade
|
| D&A For EBITDA | 4.03 | 3.79 | 2.98 | 2.11 | 2.42 | 2.77 | Upgrade
|
| EBIT | -263.93 | -173.38 | -82.38 | -78.65 | -78.04 | -62.85 | Upgrade
|
| EBIT Margin | - | -272.08% | -140.96% | -152.74% | -179.31% | - | Upgrade
|
| Revenue as Reported | 55.78 | 63.72 | 58.44 | 51.49 | 43.52 | 17.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.